A modular biosensor platform built on engineered bacteriophage tailspike proteins for sensitive detection and removal of microbes, endotoxins, and biofilms. Integrates optically active protein fusions (fluorescence, luminescence, colorimetric) for multiplexed applications in water, food, agriculture, and health sectors.
This solution offers a modular biosensor platform built on engineered bacteriophage tailspike proteins for the sensitive detection and removal of microbes and endotoxins. By fusing these proteins with optically active outputs such as GFP, Renilla luciferase, and cjBlue, the platform enables multiplexed detection across diverse pathogen targets. The technology addresses persistent challenges in water safety, food production, agriculture, and clinical diagnostics by replacing conventional chemical approaches with biologically engineered alternatives that perform reliably in complex real-world environments.
The platform is grounded in demonstrated capabilities of tailspike proteins to bind and degrade surface polysaccharides, including lipopolysaccharides (LPS), on both gram-positive and gram-negative bacterial pathogens. Beyond bacteria, the underlying protein engineering approach has been extended to fungal cell wall components and algal cell wall degradation, highlighting the versatility of the platform across microbial targets.
Core technology:
Key capabilities:
Detection features:
The underlying tailspike protein platform has been validated in published research demonstrating binding and degradation of surface polysaccharides across multiple pathogen classes. Prior work has established that LPS binding can occur independently of degradation and that specificity can be tuned through directed evolution. Fungal cell wall activity has progressed to intellectual property filing and an early-stage startup commercializing biofungicide enzymes, and algal cell wall degradation has been demonstrated in field samples for harmful algal bloom dispersal. The current stage of development focuses on generating and validating optically active protein fusions, screening fusion libraries for gain-of-signal behavior, and benchmarking detection sensitivity across output formats, including smartphone-based detection limits. The platform is advancing from laboratory-validated components toward integrated biosensor prototypes suitable for real-world deployment.
Lytos Technologies is a biosolutions platform company that engineers biology to address persistent challenges across water, food, agriculture, and health sectors. The company utilizes its proprietary LytosBI platform, which integrates computational modeling, data-driven design, and molecular biology, to develop technologies that dismantle biofilms and neutralize microbial pathogens. By focusing on fundamental biological mechanisms, Lytos creates targeted alternatives to traditional chemical approaches, aiming to provide solutions that are safer, more sustainable, and capable of performing in complex real-world environments. The company's core scientific foundation stems from research into novel anti-biofilm enzymes, which allow for the advancement of laboratory-validated innovations into scalable, field-ready biosolutions.
The company collaborates with industry, government, and institutional partners, such as the USDA and the University of Virginia, to translate scientific breakthroughs into practical applications. This partnership-driven approach ensures that their developments meet specific real-world requirements for performance, safety, and deployment. By replacing or enhancing conventional chemical methods with biological intelligence, Lytos seeks to resolve critical issues ranging from crop yield protection and food safety to environmental contamination, helping customers and stakeholders manage risks in diverse operating conditions. Through its efforts, the company aims to foster a healthier and more sustainable future by expanding the capabilities of engineered biology.